Nucleic Acid Isolation and Purification Market worth $10.99 billion in 2030
The report "Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs), Region - Global Forecast to 2030” is projected to grow from USD 7.10 billion in 2025 and to reach USD 10.99 billion in 2030, at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period.
Browse 360 market data Tables and 45 Figures spread through 400 Pages and in-depth TOC on "Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs), Region - Global Forecast to 2030”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html
The global nucleic acid isolation and purification (NAIP) market is benefiting from the growing use of NGS-based diagnostics and personalized medicine. As sequencing expands in both clinical and research labs, demand for clean, inhibitor-free DNA/RNA at the front end continues to rise. Vendors are also improving NAIP workflows through faster chemistries, higher yields, and automation-ready formats. These advances help labs scale at lower cost per sample. However, adoption can still be limited in some settings because automated extraction platforms and high-throughput setups require significant upfront investment, along with method validation and training.
The kits segment accounted for the dominant share of the global nucleic acid isolation and purification market, by product in 2024.
By product, the global NAIP market is segmented into kits, reagents, and instruments. In 2024, kits held the largest revenue share, as extraction is a repeat-use, consumables-driven workflow across routine testing and research. Magnetic bead and spin-column kits are purchased continuously as labs run daily DNA/RNA prep for PCR and NGS. Viral RNA and cfDNA/low-input kits further support spending due to tighter performance requirements and higher validation expectations. Kits are also favored because they are standardized, easy to run, and reproducible across operators and multi-site networks. As a result, recurring kit demand remains strong across hospitals and diagnostic labs, public health labs, academic institutes, and CRO/CDMO labs globally.
The hospitals & diagnostic centers segment dominated the global nucleic acid isolation and purification (NAIP) market in 2024.
By end user, the market is segmented into hospitals & diagnostic centers, academic and government research institutes, pharmaceutical & biotechnology companies, CROs, and others. In 2024, hospitals and diagnostic centers held the largest revenue share because they run high daily volumes of molecular testing. In these settings, DNA/RNA extraction is a mandatory first step for most PCR/NAAT assays and an increasing share of sequencing-based tests. This drives steady, repeat purchases of extraction kits (magnetic-bead and spin-column), reagents, and disposable plastics to support consistent turnaround and reduce reruns. As routine molecular diagnostics expands across infectious disease, oncology, and genetic screening, these end users continue to anchor global NAIP demand.
The North American region accounted for the largest share of the nucleic acid isolation and purification market in 2024.
The NGS market is segmented into six major regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is the largest regional market for nucleic acid isolation and purification offerings in 2024, while Europe is the second-largest market. North America is at the forefront largely because of its dense concentration of hospital laboratories, a few large-scale reference laboratories, and extensive public health networks that collectively run very high volumes of PCR/NAAT testing. In addition, this region boasts deep and broad penetration of NGS for clinical diagnostics as well as for research purposes, which is raising demand for the supply of consistent, high-quality DNA/RNA extraction as the initial step. Moreover, North America is characterized by very high uptake of automated and high-throughput platforms for extraction, enabling laboratories to handle the scale of their work while enhancing reproducibility and traceability. Altogether, these factors place the region as a leader in the NAIP market.
Key players in the nucleic acid isolation and purification market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Qiagen (Germany), F. Hoffman-La Roche (Switzerland), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories Inc. (US), Promega Corporation (US), New England Biolabs (US), and Takara Bio Inc. (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Nucleic Acid Isolation and Purification Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
